ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 96 filers reported holding ENDOCYTE INC in Q4 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,319,000 | -17.5% | 517,159 | 0.0% | 0.00% | – |
| Q3 2016 | $1,598,000 | -3.9% | 517,159 | -0.2% | 0.00% | – |
| Q2 2016 | $1,663,000 | +2.1% | 518,217 | -1.4% | 0.00% | – |
| Q1 2016 | $1,629,000 | -23.0% | 525,438 | -0.4% | 0.00% | – |
| Q4 2015 | $2,115,000 | -5.4% | 527,429 | +8.1% | 0.00% | – |
| Q3 2015 | $2,235,000 | +22.9% | 488,098 | +39.4% | 0.00% | – |
| Q2 2015 | $1,818,000 | -24.9% | 350,221 | -9.4% | 0.00% | – |
| Q1 2015 | $2,421,000 | -1.0% | 386,673 | -0.5% | 0.00% | – |
| Q4 2014 | $2,445,000 | +0.8% | 388,702 | -2.6% | 0.00% | – |
| Q3 2014 | $2,426,000 | -13.1% | 399,087 | -5.8% | 0.00% | – |
| Q2 2014 | $2,791,000 | -72.2% | 423,577 | +0.6% | 0.00% | -100.0% |
| Q1 2014 | $10,024,000 | +137.9% | 420,988 | +6.7% | 0.00% | +100.0% |
| Q4 2013 | $4,213,000 | -25.4% | 394,448 | -6.9% | 0.00% | 0.0% |
| Q3 2013 | $5,646,000 | +3.8% | 423,523 | +2.3% | 0.00% | 0.0% |
| Q2 2013 | $5,438,000 | – | 414,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |